What is Wavely Diagnostics?
Wavely Diagnostics is pioneering the future of remote digital diagnostics, leveraging smartphone technology to address critical needs in pediatric care and drive the expansion of telehealth services. The company's innovative approach aims to make healthcare more accessible and efficient, particularly for younger patients, by integrating advanced diagnostic capabilities into everyday mobile devices. This strategic focus positions Wavely Diagnostics as a key player in the evolving landscape of digital health and remote patient monitoring.
How much funding has Wavely Diagnostics raised?
Wavely Diagnostics has raised a total of $3.5M across 2 funding rounds:
Angel/Seed
$2.2M
Other Financing Round
$1.4M
Angel/Seed (2022): $2.2M with participation from HealthTech Capital, WXR Fund, WRF Capital, Gaingels Spark Fund, Cascade Seed Fund, and Ambit Health Ventures
Other Financing Round (2023): $1.4M led by HealthTech Capital, WRF Capital, and Robin Hood Ventures
Key Investors in Wavely Diagnostics
HealthTech Capital
HealthTech Capital is a private investment organization focused on healthtech and digital health startups, providing funding and mentoring since 2010. The company connects accredited angel investors, healthcare systems, and corporate investors to support early-stage healthtech ventures.
WRF Capital
Washington Research Foundation is a prominent early-stage investor focused on transforming innovative ideas into successful businesses based in Washington. With an annual investment of approximately $5 million, WRF Capital prioritizes startups emerging from local nonprofit research institutions, specializing in life sciences, information technology, and physical sciences.
Robin Hood Ventures
Robin Hood Ventures is a leading angel investment group based in Philadelphia, specializing in early-stage, high-growth startups. They provide investments ranging from $250,000 to $1 million and collaborate with venture capitalists and other angel investors.
What's next for Wavely Diagnostics?
With the recent infusion of major strategic capital, Wavely Diagnostics is poised for accelerated growth and further development of its remote diagnostic platform. This significant backing, part of its $3.6M in total financing, suggests a scaling phase for the company, likely focusing on expanding its market reach, enhancing its technological capabilities, and forging new partnerships within the healthcare ecosystem. The company's trajectory indicates a strong commitment to innovation in pediatric telehealth.
See full Wavely Diagnostics company page
